Also trades as: RGT.L (LSE) · $vol 0M
RGT.AX ASX
Argent BioPharma Limited
1W: -6.2%
1M: +0.0%
3M: -58.3%
YTD: -46.4%
1Y: -78.6%
A$0.03 ($0.02)
-0.00 (-6.67%)
Weekly Expected Move ±8.3%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$0
+0.0% ▲
Capital Expenditures
$2K
+98.4% ▲
Free Cash Flow
-$9M
+35.6% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
$322K
-30.6% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2024 |
|---|---|
| — Operating Activities — | |
| Net Income | $0 |
| Depreciation & Amort. | $0 |
| Stock-Based Comp. | $0 |
| Change in Working Capital | $0 |
| Other Non-Cash Items | $0 |
| Operating Cash Flow | $0 |
| — Investing Activities — | |
| Capital Expenditures | -$2K |
| Acquisitions (Net) | $0 |
| Investment Purchases | $0 |
| Investment Sales | $0 |
| Other Investing | $211K |
| Investing Cash Flow | $209K |
| — Financing Activities — | |
| Net Debt Issuance | -$200K |
| Stock Repurchased | $0 |
| Dividends Paid | $0 |
| Other Financing | -$807K |
| Financing Cash Flow | $9M |
| Net Change in Cash | $322K |
| Cash End of Period | $1M |
| Free Cash Flow | -$9M |